Repligen Corp
NASDAQ:RGEN
Repligen Corp
NASDAQ:RGEN
Price:
122.59
USD
2.07%
Market Closed
Market Cap:
$6.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Repligen Corp
NASDAQ:RGEN
|
US |
Balance Sheet
Balance Sheet Decomposition
Repligen Corp
Repligen Corp
Balance Sheet Decomposition is not available for
Repligen Corp
Repligen Corp
Balance Sheet
Repligen Corp
Repligen Corp
Currency: USD
| Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||
| Cash & Cash Equivalents |
11
|
29
|
40
|
35
|
54
|
122
|
174
|
194
|
528
|
717
|
604
|
524
|
751
|
757
|
566
|
|
| Cash Equivalents |
11
|
29
|
40
|
35
|
54
|
122
|
174
|
194
|
528
|
717
|
604
|
524
|
751
|
757
|
566
|
|
| Short-Term Investments |
15
|
11
|
22
|
23
|
18
|
20
|
0
|
0
|
0
|
0
|
0
|
100
|
0
|
0
|
202
|
|
| Total Receivables |
6
|
13
|
12
|
8
|
12
|
16
|
28
|
37
|
46
|
74
|
121
|
117
|
124
|
134
|
159
|
|
| Accounts Receivables |
3
|
4
|
5
|
8
|
11
|
15
|
28
|
33
|
43
|
71
|
117
|
116
|
124
|
134
|
159
|
|
| Other Receivables |
3
|
9
|
7
|
1
|
0
|
1
|
0
|
4
|
3
|
3
|
4
|
1
|
0
|
0
|
0
|
|
| Inventory |
13
|
11
|
12
|
12
|
18
|
25
|
39
|
42
|
55
|
95
|
185
|
238
|
202
|
143
|
170
|
|
| Other Current Assets |
1
|
2
|
1
|
2
|
2
|
2
|
2
|
3
|
12
|
16
|
22
|
19
|
34
|
32
|
41
|
|
| Total Current Assets |
47
|
66
|
86
|
81
|
103
|
184
|
243
|
276
|
642
|
902
|
932
|
998
|
1 111
|
1 066
|
1 137
|
|
| PP&E Net |
11
|
10
|
13
|
15
|
14
|
15
|
22
|
32
|
74
|
92
|
227
|
316
|
323
|
333
|
306
|
|
| PP&E Gross |
11
|
10
|
13
|
15
|
14
|
15
|
22
|
32
|
74
|
92
|
227
|
316
|
323
|
333
|
306
|
|
| Accumulated Depreciation |
8
|
10
|
12
|
14
|
17
|
19
|
24
|
28
|
35
|
49
|
71
|
92
|
129
|
162
|
204
|
|
| Intangible Assets |
8
|
7
|
6
|
15
|
13
|
30
|
145
|
135
|
213
|
287
|
337
|
354
|
407
|
398
|
386
|
|
| Goodwill |
1
|
1
|
1
|
14
|
14
|
60
|
327
|
327
|
468
|
618
|
860
|
856
|
987
|
1 031
|
1 114
|
|
| Long-Term Investments |
9
|
10
|
12
|
4
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
3
|
0
|
1
|
1
|
1
|
6
|
5
|
3
|
3
|
3
|
2
|
3
|
2
|
6
|
|
| Other Assets |
1
|
1
|
1
|
14
|
14
|
60
|
327
|
327
|
468
|
618
|
860
|
856
|
987
|
1 031
|
1 114
|
|
| Total Assets |
76
N/A
|
97
+27%
|
119
+22%
|
128
+8%
|
146
+14%
|
289
+98%
|
744
+157%
|
775
+4%
|
1 400
+81%
|
1 903
+36%
|
2 358
+24%
|
2 525
+7%
|
2 831
+12%
|
2 830
0%
|
2 950
+4%
|
|
| Liabilities | ||||||||||||||||
| Accounts Payable |
1
|
3
|
2
|
4
|
7
|
5
|
7
|
11
|
11
|
17
|
36
|
28
|
20
|
32
|
30
|
|
| Accrued Liabilities |
6
|
8
|
7
|
6
|
12
|
14
|
15
|
14
|
28
|
42
|
64
|
56
|
39
|
63
|
83
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
104
|
0
|
244
|
255
|
285
|
69
|
0
|
0
|
|
| Other Current Liabilities |
1
|
1
|
2
|
1
|
0
|
2
|
3
|
2
|
9
|
17
|
20
|
36
|
37
|
32
|
23
|
|
| Total Current Liabilities |
8
|
11
|
11
|
11
|
19
|
21
|
25
|
130
|
48
|
319
|
375
|
404
|
165
|
127
|
136
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
95
|
99
|
0
|
233
|
0
|
0
|
0
|
510
|
526
|
542
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
25
|
25
|
30
|
27
|
34
|
23
|
39
|
23
|
22
|
|
| Other Liabilities |
3
|
2
|
4
|
6
|
5
|
4
|
2
|
4
|
29
|
28
|
200
|
187
|
152
|
182
|
143
|
|
| Total Liabilities |
10
N/A
|
13
+28%
|
15
+15%
|
17
+12%
|
24
+42%
|
120
+411%
|
152
+27%
|
159
+5%
|
340
+114%
|
374
+10%
|
608
+63%
|
614
+1%
|
866
+41%
|
857
-1%
|
844
-2%
|
|
| Equity | ||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Retained Earnings |
119
|
105
|
89
|
81
|
72
|
60
|
32
|
16
|
6
|
66
|
194
|
397
|
433
|
407
|
456
|
|
| Additional Paid In Capital |
185
|
187
|
191
|
198
|
203
|
242
|
629
|
643
|
1 068
|
1 461
|
1 572
|
1 547
|
1 569
|
1 617
|
1 652
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
2
|
2
|
6
|
9
|
14
|
6
|
12
|
15
|
2
|
17
|
34
|
38
|
53
|
3
|
|
| Total Equity |
66
N/A
|
84
+27%
|
104
+24%
|
112
+8%
|
123
+10%
|
169
+38%
|
592
+250%
|
616
+4%
|
1 060
+72%
|
1 529
+44%
|
1 750
+14%
|
1 911
+9%
|
1 965
+3%
|
1 973
+0%
|
2 106
+7%
|
|
| Total Liabilities & Equity |
76
N/A
|
97
+27%
|
119
+22%
|
128
+8%
|
146
+14%
|
289
+98%
|
744
+157%
|
775
+4%
|
1 400
+81%
|
1 903
+36%
|
2 358
+24%
|
2 525
+7%
|
2 831
+12%
|
2 830
0%
|
2 950
+4%
|
|
| Shares Outstanding | ||||||||||||||||
| Common Shares Outstanding |
31
|
31
|
32
|
33
|
33
|
34
|
44
|
44
|
52
|
55
|
55
|
56
|
56
|
56
|
56
|
|
Switch to:
Switch to:
See Also
Discover More
